We are live on ! Find out more
PFS

Physicians Financial Services Portfolio holdings

AUM $401M
1-Year Est. Return 34.09%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+34.09%
3 Year Est. Return
+100.43%
5 Year Est. Return
+135.13%
10 Year Est. Return
+502.74%
AUM
$170M
AUM Growth
+$9.04M
Cap. Flow
+$4.17M
Cap. Flow %
2.45%
Top 10 Hldgs %
33.55%
Holding
124
New
10
Increased
52
Reduced
39
Closed
4

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$396K
2
AAPL icon
Apple
AAPL
+$345K
3
ALC icon
Alcon
ALC
+$340K
4
AMGN icon
Amgen
AMGN
+$329K
5
SHW icon
Sherwin-Williams
SHW
+$323K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$462K
2
T icon
AT&T
T
+$440K
3
WOLF icon
Wolfspeed
WOLF
+$279K
4
COP icon
ConocoPhillips
COP
+$256K
5
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$245K

Sector Composition

Rank Sector Weight
1 Technology 18.74%
2 Industrials 16.78%
3 Consumer Staples 15.21%
4 Consumer Discretionary 13.33%
5 Financials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
76
Abbott
ABT
$180B
$510K 0.3%
6,062
-200
-3% -$15.7K
BUD icon
77
AB InBev
BUD
$158B
$491K 0.29%
5,550
-100
-2% -$8.58K
SYK icon
78
Stryker
SYK
$127B
$467K 0.27%
2,270
MO icon
79
Altria Group
MO
$122B
$464K 0.27%
9,809
-185
-2% -$9.69K
KMB icon
80
Kimberly-Clark
KMB
$36.4B
$439K 0.26%
3,292
-160
-5% -$20.6K
SWKS icon
81
Skyworks Solutions
SWKS
$9.06B
$434K 0.26%
5,620
-123
-2% -$9.75K
RDS.B
82
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$426K 0.25%
6,487
-338
-5% -$22K
BDX icon
83
Becton Dickinson
BDX
$43.1B
$421K 0.25%
1,714
+359
+26% +$83.4K
SLB icon
84
SLB Ltd
SLB
$77.8B
$416K 0.24%
10,480
+300
+3% +$12.1K
HP icon
85
Helmerich & Payne
HP
$3.53B
$406K 0.24%
8,030
-250
-3% -$13.8K
SAP icon
86
SAP
SAP
$187B
$383K 0.23%
2,799
MDT icon
87
Medtronic
MDT
$107B
$379K 0.22%
3,891
+300
+8% +$27.4K
EMR icon
88
Emerson Electric
EMR
$82.9B
$378K 0.22%
5,661
-100
-2% -$6.7K
ALC icon
89
Alcon
ALC
$33.1B
$360K 0.21%
+5,800
New +$340K
WFC icon
90
Wells Fargo
WFC
$261B
$360K 0.21%
7,600
-725
-9% -$33.9K
PAYX icon
91
Paychex
PAYX
$40.4B
$358K 0.21%
4,352
COLM icon
92
Columbia Sportswear
COLM
$3.19B
$331K 0.19%
3,300
+100
+3% +$9.92K
SHW icon
93
Sherwin-Williams
SHW
$78.3B
$330K 0.19%
+2,160
New +$323K
NOC icon
94
Northrop Grumman
NOC
$77B
$323K 0.19%
1,000
T icon
95
AT&T
T
$165B
$321K 0.19%
12,672
-18,360
-59% -$440K
DAL icon
96
Delta Air Lines
DAL
$55.9B
$318K 0.19%
+5,600
New +$314K
CHD icon
97
Church & Dwight Co
CHD
$23.1B
$311K 0.18%
4,259
+200
+5% +$14.9K
WYNN icon
98
Wynn Resorts
WYNN
$10.1B
$310K 0.18%
+2,500
New +$321K
LLY icon
99
Eli Lilly
LLY
$1.07T
$307K 0.18%
2,768
-270
-9% -$31.8K
SJM icon
100
J.M. Smucker
SJM
$12.6B
$307K 0.18%
2,665
+50
+2% +$6.11K

Similar funds

Physicians Financial Services's Q2 2019 Portfolio in Review

As of Q2 2019, Physicians Financial Services held 124 positions worth $170M, up 5.6% from $161M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Physicians Financial Services's Q2 2019 filing shows 10 new, 52 increased, 39 reduced and 4 closed positions. Its largest new stake was Alcon: 5,800 shares worth $360K. The largest sale was Novartis, an estimated $462K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Staples.

  • Physicians Financial Services's largest Q2 2019 buy was Alcon: 5,800 shares worth $360K.
  • Physicians Financial Services added most to 3M in Q2 2019, an estimated $396K increase.
  • Physicians Financial Services's biggest Q2 2019 reduction was Novartis, cutting an estimated $462K.
  • Physicians Financial Services fully exited Wolfspeed in Q2 2019, selling an estimated $279K.
  • Physicians Financial Services's ten largest holdings make up 34% of its $170M portfolio in Q2 2019.
  • Physicians Financial Services opened 10 new positions and closed 4 in Q2 2019.
  • Physicians Financial Services's portfolio value rose 5.6% quarter-over-quarter to $170M.

Based on Physicians Financial Services's 13F filing for Q2 2019, filed 12 Aug 2019.